Serum – Please provide the time since the last dose
Only available for monitoring the use of Methotrexate as a chemotherapy for haematological malignancies. This test is not indicated for monitoring RA treatment.
umol/L
Measurements are vital during high-dose methotrexate treatment phases in leukaemic patients. Please notify the laboratory that monitoring will be required before treatment commences.
For interpretation of results, please contact a Consultant Haematologist.
1 day
Local test
Cannot be added on to an existing request
Specimen Labelling Procedure
8210
